"SCOTUS Immigration Rulings Highlight Ongoing Cruelty"

📈 Markets — The average Thrift Savings Plan (TSP) balance for federal employees is projected to change by age in 2026, prompting a closer look at new contribution limits. This data helps individuals assess their retirement readiness and financial goals. Meanwhile, Polymarket faces federal investigation amid scrutiny from senators following a Wall Street Journal report, raising concerns about its operations in the prediction market space.

⚽ MLS — Aberdeen has strengthened their squad by signing Moroccan striker Ayoub Mouloua from FUS Rabat on a three-year deal. Mouloua, who scored six goals in 21 appearances last season, adds depth to the team as they look to improve their performance.

🎓 College Football — Michael Bratton, host of That SEC Podcast, predicts Texas A&M will finish the upcoming season with a 10-2 record, facing tough competition from Oklahoma and Texas. As analysts delve into the 2026 schedule, fans are eager to see how the Aggies will fare in the SEC landscape.

💻 Big Tech — The Nigerian government is focusing on micro, small, and medium enterprises (MSMEs) to drive economic growth and improve livelihoods. This initiative includes targeted infrastructure projects and business-support grants aimed at fostering a sustainable enterprise-led economy.

🤖 AI — A lawsuit claims that an AI company and over 1,700 gas stations in California are using algorithms to unlawfully inflate fuel prices. This practice has drawn attention from major retailers and could have significant legal implications for the industry.

🇺🇸 U.S. Politics — The Supreme Court's recent immigration rulings indicate a shift away from the previously held notion of compassionate conservatism, raising concerns about the treatment of vulnerable populations. In Philadelphia, a national park exhibit on slavery faces scrutiny as local officials vow to preserve its integrity amid pressures for change from the Trump administration. This juxtaposition of local and national narratives highlights ongoing debates about history and justice in the U.S.

💊 Pharma — The little blue pill for erectile dysfunction, originally developed as a treatment for chest pain, showcases an unexpected twist in pharmaceutical history. Pfizer's early trials revealed a side effect that men were eager to keep, leading to the drug's massive commercial success. This story highlights how innovation often comes from unforeseen outcomes in medical research.